INFOGRAPHIC: Scientific Advancements: Next-Generation ETs in ER+, HER2-, ABC
This infographic provides an overview of the approved and investigational ET classes in ER+, HER2-, ABC; highlights the potential benefits of next-generation ETs, resulting in more potent endocrine pathway antagonism
Date of Last Review: March 28, 2024
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice